HDFC Pharma and Healthcare Fund vs Nippon India Pharma Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Nippon India Pharma Fund-Growth Plan-Growth Option
Chart Comparison
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹1383 Cr | ₹8689 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹500 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 28 Sep 2023 | 05 Jun 2004 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | BSE Healthcare |
| Turn Over | % | 21% |
| Expense Ratio | 2.17 | 1.81 |
| Manager | Dhruv Muchhal | Sailesh Raj Bhan |
| ISIN Code | INF179KC1HL7 | INF204K01968 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Month | -5.41% | -7.66% |
| 6 Month | 9.42% | -1.35% |
| 1 Year | 34.7% | 16.46% |
| 3 Year | - | 18.68% |
| 5 Year | - | 25.21% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 6 Month | - | - |
| 1 Year | 41.75% | 24.47% |
| 3 Year | - | 31.12% |
| 5 Year | - | 25.01% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| 1 Year | 62.28% | 17.79% |
| 3 Year | - | 20.87% |
| 5 Year | - | 20.18% |
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Standard Deviation | - | 14.36% |
| Sharp | - | 0.78% |
| Beta | - | 0.87% |
| Alpha | - | 1.67% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Name | Dhruv Muchhal | Sailesh Raj Bhan |
| Total AUM | ₹520687 Cr | ₹96086 Cr |
| Fund Manage | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Nippon India Pharma Fund-Growth Plan-Growth Option |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.98 | 4.4 |
| Small Cap | 33.12 | 22.52 |
| Large Cap | 32.5 | 45.96 |
| Mid Cap | 32.4 | 27.12 |
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Nippon India Pharma Fund-Growth Plan-Growth Option |
|---|---|---|
| Others | 1.98 | 4.4 |
| Pharmaceuticals & Biotechnology | 74.71 | 75.86 |
| Healthcare Services | 22.28 | 17.38 |
| Retailing | 1.03 | 2.36 |
Top Comparisons
Mahindra Manulife Focused Fund - Regular Plan - Growth
3Y Returns17.92%
HSBC Focused Fund - Regular Growth
3Y Returns12.96%
Franklin India Feeder - Templeton European Opportunities Fund - Growth
3Y Returns3.23%
Axis Global Innovation Fund of Fund - Regular Plan - Growth
3Y Returns12.81%
Motilal Oswal Nasdaq 100 Fund of Fund- Regular Plan Growth
3Y Returns23.19%
Edelweiss Asean Equity Off-shore Fund - Regular Plan - Growth Option
3Y Returns5.69%
Baroda BNP Paribas Retirement Fund - Reg (G)
3Y Returns0%
Tata Nifty500 Multicap Infrastructure 50:30:20 Index Fund-Reg (G)
3Y Returns0%